Defining and managing suicidal risk in patients taking psychotropic medications.
Fawcett
Jan A
JA
Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Baldessarini
Ross J
RJ
Coryell
William H
WH
Silverman
Morton M
MM
Stein
Dan J
DJ
D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003430:Cross-Sectional Studies; D003866:Depressive Disorder / Q000188:drug therapy*; D004348:Drug Labeling; D006760:Hospitalization; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D016017:Odds Ratio; D011619:Psychotropic Drugs / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data; D013406:Suicide, Attempted / Q000517:prevention & control* / Q000523:psychology / Q000706:statistics & numerical data; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult; D000092864:Suicide Prevention
D000928:Antidepressive Agents; D011619:Psychotropic Drugs